Importance of uncharged polar residues and proline in the proximal two-thirds (Pro107–Ser128) of the highly conserved region of mouse ileal Na+-dependent bile acid transporter, Slc10a2, in transport activity and cellular expression
© Saeki et al.; licensee BioMed Central Ltd. 2013
Received: 22 May 2012
Accepted: 31 January 2013
Published: 4 February 2013
SLC10A2-mediated reabsorption of bile acids at the distal end of the ileum is the first step in enterohepatic circulation. Because bile acids act not only as detergents but also as signaling molecules in lipid metabolism and energy production, SLC10A2 is important as the key transporter for understanding the in vivo kinetics of bile acids. SLC10A family members and the homologous genes of various species share a highly conserved region corresponding to Gly104–Pro142 of SLC10A2. The functional importance of this region has not been fully elucidated.
To elucidate the functional importance of this region, we previously performed mutational analysis of the uncharged polar residues and proline in the distal one-third (Thr130–Pro142) of the highly conserved region in mouse Slc10a2. In this study, proline and uncharged polar residues in the remaining two-thirds of this region in mouse Slc10a2 were subjected to mutational analysis, and taurocholic acid uptake and cell surface localization were examined. Cell surface localization of Slc10a2 is necessary for bile acid absorption. Mutants in which Asp or Leu were substituted for Pro107 (P107N or P107L) were abundantly expressed, but their cell surface localization was impaired. The S126A mutant was completely impaired in cellular expression. The T110A and S128A mutants exhibited remarkably enhanced membrane expression. The S112A mutant was properly expressed at the cell surface but transport activity was completely lost. Replacement of Tyr117 with various amino acids resulted in reduced transport activity. The degree of reduction roughly depended on the van der Waals volume of the side chains.
The functional importance of proline and uncharged polar residues in the highly conserved region of mouse Slc10a2 was determined. This information will contribute to the design of bile acid-conjugated prodrugs for efficient drug delivery or SLC10A2 inhibitors for hypercholesterolemia treatment.
KeywordsBile acid Enterohepatic circulation Ileal sodium-dependent bile acid transporter
Bile acids are synthesized from cholesterol in the liver and secreted into the small intestine as components of bile for the digestion and absorption of lipids and lipid-soluble vitamins. In addition to the detergent action of bile acids, which aids in the digestion and absorption of lipid and lipid-soluble nutrients by forming micelles with biliary phospholipids and cholesterol, bile acids are now appreciated as signaling molecules that control lipid metabolism and energy production [1–6]. At the distal end of the ileum, 95%–98% of bile acids are effectively reabsorbed by an ileal sodium-dependent bile acid transporter (SLC10A2, also designated ASBT, ISBT, or IBAT) and returned to the liver via portal circulation. Among the transporters that are expressed in the liver, intestine, and bile duct and are involved in enterohepatic circulation of bile acids, SLC10A2 is the key transporter for understanding the in vivo kinetics of bile acids given that reabsorption of bile acids by SLC10A2 is the first step in enterohepatic circulation. SLC10A2 is the second member of the solute carrier family 10, and consists of 348 amino acids. SLC10A2 is expressed in the ileum, cholangiocytes, and kidney, and contributes to the maintenance of the bile acid pool and cholesterol homeostasis [7–9]. Transport of bile acids by SLC10A2 is facilitated by sodium symport in an electrogenic process with a 2:1 Na+/bile acid stoichiometry . Given that bile acids are synthesized from cholesterol, inhibition of bile acid reabsorption via SLC10A2 inhibition has been used as a cholesterol-lowering therapy. Moreover, due to its high transport capacity in the ileum, SLC10A2 is also an attractive target for the prodrug strategy to enhance drug bioavailability [11, 12].
The membrane topology and detailed transport mechanism of SLC10A2 have been studied. Hydropathy analysis and membrane insertion scanning revealed that SLC10A2 has an extracellular N-terminus and a cytoplasmic C-terminus [13, 14]. The exact membrane topology remains controversial: in vitro translation studies using membrane insertion scanning suggested a 9-transmembrane (TM) topology, whereas N-glycosylation scanning mutagenesis and dual-label epitope insertion scanning mutagenesis support a 7-TM topology [13–19]. The recently published crystal structure of a bacterial homolog of SLC10A2 from Neisseria meningitidis (designated ASBTNM) supports the 9-TM topology .
Protein regions and amino acid residues of SLC10A2 involved in membrane trafficking, substrate recognition, and substrate permeation have been identified. The cytoplasmic tail of rat Slc10a2 acts as a sorting signal for apical trafficking, and Ser335 and Thr339 phosphorylations are crucial for apical targeting . Computational analysis based on homology-modeling and remote-threading techniques revealed that Asp282 and Leu283 of human SLC10A2 are involved in hydrogen bond formation with the 12α-hydroxyl group of bile acids . A series of analyses using the substituted-cysteine accessibility method revealed that in the 7-TM model TM7 (Phe287–Tyr308) lines the substrate translocation pathway, TM4 (Ile160–Met180) forms part of the pathway, Asp124 interacts with the 7α-hydroxyl group of bile acids, and the extracellular loop (EL) 1 corresponding to Val99–Ser126 acts as a Na+ sensor [22–24]. Glu261 in EL3 has also been shown to act as a Na+ sensor, and EL1 and EL3 have been proposed to act as re-entrant loop segments [25, 26]. Despite such extensive studies, the mechanisms underlying the binding and transport of bile acids remain unclear.
To determine the involvement of these residues in substrate recognition, transport, and intracellular sorting and/or stability of mSlc10a2, taurocholic acid (TCA) transport and cell surface localization were analyzed.
To evaluate the ability of the mutants to transport bile acids, TCA uptake by the wild-type and mutant mSlc10a2 was compared (Figure 3B). Because cellular expression of S126A was not detected, this mutant was omitted from further analysis. The S128A mutant exhibited uptake levels comparable to that of wild type, and TCA uptake by the T110A mutant was significantly higher than that of wild type. TCA uptake by the Y117F mutant was approximately half that by the wild type, but the difference was not statistically significant. S112A did not exhibit Na+-dependent TCA uptake.
Kinetic values for taurocholic acid transport by wild-type and polar-residue mutant mouse Slc10a2 proteins
The cellular localization of the expressed transporters was investigated by cell surface biotinylation (Figure 3D). The fully glycosylated form was predominantly detected in the biotinylated fraction. Membrane expression of Y117F was similar to that of wild type, and the membrane expression of T110A and S128A was significantly higher than that of wild type, suggesting that removal of the polar hydroxyl group from Thr110 and Ser128 improved membrane sorting and/or stability of mSlc10a2. Although S112A was a loss-of-function mutation, membrane expression of the mutant was clearly detected, indicating that Ser112 is critical for the activity of mSlc10a2.
To compare the activities of the mutant transporters, the Na+-dependent TCA uptake by wild-type and mutant mSlc10a2 was normalized to the cell surface expression of the corresponding proteins (Figure 3E). The normalized Vmax of the T110A mutant (1600  pmol·mg protein–1·min–1) was similar to that of the wild type (1620  pmol·mg protein–1·min–1), indicating that the difference in the apparent TCA transport activity of this mutant was mainly due to the different level of its expression at the cell surface. By contrast, the apparently higher activity of S128A could not be explained by abundant membrane expression because the normalized Vmax of the S128A mutant (2410  pmol·mg protein–1·min–1) was remarkably higher than that of wild type. The normalized Vmax value of the Y117F mutant (1170  pmol·mg protein–1·min–1) was lower than that of wild type.
Optimal function of SLC10A2 is required for bile acid reabsorption in the ileum. Impairment of this function not only affects cholesterol homeostasis but may also increase the possibility of colorectal tumorigenesis due to increased flow of bile acids into the large intestine. Indeed, prevention of bile acid reabsorption by surgical removal of the ileum increased colonic tumorigenesis in rats fed deoxycholic acid . The C to T polymorphism at codon 169 of the human SLC10A2 gene is associated with colorectal adenomas, indicating the role of bile acids in the etiology of this disease . A genetic polymorphism associated with primary bile acid malabsorption (PBAM) or idiopathic intestinal bile acid malabsorption (IBAM) has been identified, and mutations that abolish transport function (L243P and T262M) and a haplotype block linked to reduced expression have been reported for human SLC10A2 [31, 32]. This polymorphism has not been mapped in the highly conserved region, and the importance of the cluster of conserved residues has not yet been fully clarified. Toward the end of the study presented here, the crystal structure of ASBTNM was reported, and some of the residues were indicated to form a part of the Na+-binding pocket .
We have previously reported the importance of Pro142, which is located at the distal end of the highly conserved region . Substitution of Pro142 with Val completely impaired cell surface localization of mSlc10a2. This is consistent with our results from the mutational analysis of Pro107 showing that Asn or Leu substitution for Pro107 impaired cell surface expression of mSlc10a2, resulting in the loss of transport activity. In the 9-TM model, Pro107 is located in the middle of TM3. Proline acts as a “helix breaker” due to its inability to form hydrogen bonds with neighboring residues; therefore, TM3 would be bent at Pro107, forming hydrophobic and amphipathic half helices. Indeed, the crystal structure of ASBTNM suggests that the helix that contains Pro107 is broken precisely at this residue . In the 7-TM model, Pro107 is located in the EL between TM2 and TM3. In the ER, immediately after the synthesis of the nascent protein, this loop faces the lumen. Substitution of Pro107 with Asn or Leu may have introduced an interaction of this loop with other ELs or ER factors, resulting in detention of the mutant Slc10a2. In either case, failure of the Pro107 mutants to localize to the cell surface suggests that the peculiar nature of proline, an imino acid, and not the hydrophobicity or bulkiness of the side chain is important for intracellular sorting. Given that proline at this position is highly conserved in the related proteins, it is expected to be crucial for function through correct secondary structure formation and cellular localization.
Ser112 was considered indispensable for the synthesis or stability of human SLC10A2 because replacement of Ser112 with Cys completely abolished expression . In this study, however, Ala substitution of Ser112 did not impair membrane expression of mSlc10a2, whereas TCA transport activity was completely lost. This suggests that Ser112 is not critical for mSlc10a2 expression but is essential for TCA transport activity. Based on the crystal structure of ASBTNM, Ser112 of mSlc10a2 is thought to bind Na+ with its side chain . Ser is conserved at this position in all the related proteins except SLC10A5 (Figure 1), suggesting that this residue is also critical in all the other members.
Expression of the S126A mutant was undetectable even in whole cell lysates. This is consistent with a previous report showing the failure of expression of the human SLC10A2 S126C mutant . This residue has been suggested to bind Na+, and it is likely that Ser126 plays an important role in the other members as well, given that this residue is conserved in all the genes except those encoding SLC10A3 and SLC10A5.
Because Thr110 and Ser128 are not conserved in the related proteins, particularly in the Na+-dependent bile acid transporter SLC10A1 (also designated NTCP or BSBT), which is expressed on the sinusoidal membrane of hepatocytes, it is unlikely that these residues are involved in the interaction with bile acids. The apparently higher membrane expression of the T110A and S128A mutants suggests that these residues may be involved in the negative regulation of stability or intracellular sorting via formation of higher-order structures or interaction with cellular cofactors.
The Phe substitution for Tyr117, which removes a polar hydroxyl group, reduced the transport activity of mSlc10a2; however, substrate affinity was not affected. This result was inconsistent with the previous finding that the Y117C mutation completely impaired membrane expression of human SLC10A2. To resolve this discrepancy, we replaced Tyr117 of mSlc10a2 with various amino acids and examined cellular localization and transport activities. None of the residues substituted for Tyr117 affected cell surface expression of mSlc10a2; however, the apparent transport activities were reduced. The reason for the contradiction between our results and the results of the Y117C mutation in human SLC10A2 is not clear, but a difference in the amino acid sequence context between mSlc10a2 and the human counterpart or undefined differences in experimental conditions may have affected the results. The relationship between the apparent activities and physicochemical properties of the residues were analyzed. Hydrophobicity and polarity did not correlate with activity (data not shown), but a weak correlation was observed between the van der Waals volumes of the residues and the activities of the mutants (Figure 4E). However, the correlation was not statistically significant (p = 0.0705), because the Y117W mutant with the bulkiest side chain exhibited moderate activity, and substitution with Ile and Leu, which have relatively bulky side chains, elicited low transport activities, suggesting that the volume of the side chain as well as its shape are important at this position. Although the crystal structure of ASBTNM indicated that Tyr117 does not directly interact with Na+ or taurocholate, it is obvious that this residue is important for the molecular activity of the transporter. Tyr117 may be involved in conformational changes during TCA transport.
In this study, residues critical for transport activity, expression, and stability and/or intracellular trafficking, but not substrate recognition, were identified within the proximal two-thirds of the highly conserved region. Functionally important residues are clustered in the highly conserved region. Due to the specific and high transport capacity of SLC10A2 in the ileum, bioavailability of drugs may be enhanced by designing them as bile acid-conjugated prodrugs. The information on functionally critical residues will contribute to the design of prodrugs for efficient drug delivery and SLC10A2 inhibitors for treatment of hypercholesterolemia.
[G-3H]TCA was purchased from Perkin-Elmer (Waltham, MA) and American Radiolabeled Chemicals (St. Louis, MO). Unlabeled sodium taurocholate was purchased from Nacalai Tesque (Kyoto, Japan). The Cell Surface Protein Isolation Kit, which included sulfosuccinimidyl 2-(biotinamido)ethyl-1,3-dithiopropionate (sulfo-NHS-SS-biotin), was purchased from Pierce (Rockford, IL). Streptavidin agarose was purchased from Merck (Darmstadt, Germany). The anti-green fluorescent protein (GFP) monoclonal antibody was purchased from Nacalai Tesque. The anti-T7 tag monoclonal antibody was purchased from Merck. The anti-calnexin rabbit polyclonal antibody was from Novus Biologicals (Littleton, CO). Secondary antibodies (horseradish peroxidase (HRP)-conjugated anti-mouse, anti-rat, and anti-rabbit IgG) were purchased from Nacalai Tesque. Fluorescein-labeled anti-mouse secondary antibody was purchased from Kirkegaard & Perry Laboratories (Gaithersburg, MD). The cloning vector pUC119 was purchased from Takara Bio (Shiga, Japan). The mammalian expression vectors pEGFP-N1 and pZeoSV2(+) were purchased from Clontech (Shiga, Japan) and Invitrogen (Tokyo, Japan), respectively. Mutagenic oligonucleotide primers for site-directed mutagenesis were custom synthesized and purchased from Invitrogen. Site-directed mutagenesis of Pro107 and uncharged polar residues was performed using the Quickchange II Site-Directed Mutagenesis Kit purchased from Stratagene (La Jolla, CA). Site-directed mutagenesis of Tyr117 was performed using the PrimeSTAR Mutagenesis Basal Kit purchased from Takara Bio.
The simian kidney fibroblast cell line COS-7 was grown in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum (FBS), 4 mM l-Gln, and 0.1 mg/mL kanamycin sulfate. The porcine kidney cell line LLC-PK1 was grown in M199 medium supplemented with 10% FBS and 0.1 mg/mL kanamycin. Cells were cultured at 37°C in a humidified atmosphere of 5% CO2.
Construction of expression vectors
The mSlc10a2 cDNA encoding the full-length transporter (molecular weight, 38 kDa) was cloned in our laboratory . Wild-type or mutant mSlc10a2 was expressed as a fusion protein with enhanced green fluorescent protein (EGFP) or a T7 tag. The expression vectors for EGFP-fused mSlc10a2 were constructed as previously reported . To construct the expression vector for T7-tagged mSlc10a2, an Eco RI recognition site was introduced at the start codon by polymerase chain reaction (PCR) using the 5′ primer 5′-CGAATTCAGATG GATAACTCCTCTGTCTG-3′, in which the underlined portion represents the start codon, and the 3′ primer 5′-GAAGGATCCCCATGGTCTCTTTATATGTCC-3′ corresponding to nucleotides 178–207 of the coding region in which a Bam HI site was introduced without affecting the amino acid sequence. The amplified fragment was cloned into pUC119 and sequenced to confirm the absence of PCR-derived mutations. The Eco RI-Bam HI fragment obtained from the amplified clone and the remaining part of the coding region were cloned into pZeoSV2(+), and a double-stranded synthetic oligonucleotide encoding the T7 tag next to the start codon (top strand, 5′-CTAGCATGGGGATGGCTAGCATGACTGGTGGACAACAGATGGGT GG-3′; bottom strand, 5′-AATTCCACCCATCTGTTGTCCACCAGTCATGCTAGCCAT CCCCATG-3′, where the underlined portions represent the T7 tag) was inserted at the Nhe I and Eco RI sites to construct an expression vector designated pSV40-T7-mSLC10A2.
An Eco RI-Bam HI restriction fragment corresponding to nucleotides 1–589 of the coding region of mSlc10a2 cDNA was cloned into pUC119, and site-directed mutagenesis was performed according to the manufacturer’s instructions. Mutagenesis of Pro107 was performed using synthetic double-stranded primers (sense primer, 5′-GCTAATTATGGGTTGCTGCNNN GGAGGAACTGGCTCC-3′; and antisense primer, 5′-GGAGCCAGTTCCTCCNNN GCAGCAACCCATAATTAGC-3′; where the underlined portions represent the Pro107 codon, and N indicates a randomized nucleotide). Following nucleotide sequence analysis, 2 clones with Asn and Leu substitutions for Pro107 were obtained. Mutagenesis of uncharged polar residues was performed using synthetic double-stranded primers (T110A sense primer, 5′-GCTGCCCTGGAGGAGCT GGCTCCAATATCC-3′, and antisense primer, 5′-GGATATTGGAGCCAGC TCCTCCAGGGCAGC-3′; S112A sense primer, 5′-CTGGAGGAACTGGCGCC AATATCCTGGCC-3′, and antisense primer, 5′-GGCCAGGATATTGGC GCCAGTTCCTCCAG-3′; Y117F sense primer, 5′-GCTCCAATATCCTGGCCTTT TGGATAGATGGCG-3′, and antisense primer, 5′-CGCCATCTATCCAAAA GGCCAGGATATTGGAGC-3′; S126A sense primer, 5′-GGCGACATGGACCTCGCT GTTAGCATGACCACTTGC-3′, and antisense primer, 5′-GCAAGTGGTCATGCTAACAGC GAGGTCCATGTCGCC-3′; S128A sense primer, 5′-CATGGACCTCAGTGTTGCC ATGACCACTTGCTCCAC-3′, and antisense primer, 5′-GTGGAGCAAGTGGTCATGGC AACACTGAGGTCCATG-3′; where the underlined portions represent the target codons). Mutagenesis of Tyr117 was performed using synthetic double-stranded primers (sense primer, 5′-CTGGCCTAT TGGATAGATGGCGACAT-3′; and antisense primer, 5′-TATCCAATA GGCCAGGATATTGGAGCC-3′; the underlined portions represent the Tyr117 codon of wild-type mSlc10a2, and this codon was replaced with the following sequences: Y117A, GCT; Y117C, TGT; Y117H, CAT; Y117I, ATT; Y117L, CTT; Y117S, TCT; Y117T, ACT; Y117V, GTT; Y117W, TGG). All the mutations were verified by DNA sequencing. The corresponding segment of the expression vector was replaced with the restriction fragment containing the expected mutation.
Transient expression and TCA uptake
On the day before transfection, 2.4 × 105 COS-7 cells were seeded in a 3.5-cm dish. The cells were transfected with appropriate expression vectors using Lipofectamine and Plus reagent (both purchased from Invitrogen), according to the manufacturer’s instructions. Two days after transfection, uptake of 3H-TCA was measured as previously described with slight modifications . The cells were washed twice with a wash buffer (10 mM Tris-HCl, pH 7.4, 200 mM mannitol), and were then covered with 1 mL of uptake buffer (10 mM Tris-HCl, pH 7.4, 100 mM NaCl or choline chloride, 3 mM K2HPO4) containing the indicated concentration of 3H-TCA and incubated at 37°C. The reaction was stopped by washing cells twice with 1 mL of ice-cold wash buffer, and cells were lysed in 1 mL of 0.2 M NaOH. Cell-associated radioactivity was measured using a liquid scintillation counter (Perkin-Elmer) and normalized to the total protein content determined using the Bradford method with bovine serum albumin as a concentration standard. For quantitative transport analysis, TCA was used at a concentration range much lower than the critical micellar concentration.
Apparent Km and Vmax values for TCA uptake were determined by measuring the initial rates of uptake at various concentrations of taurocholate. The TCA concentration was adjusted by adding unlabeled TCA. The data were fitted to the Michaelis-Menten equation by nonlinear regression using the KaleidaGraph 4.0 software (Synergy Software, Reading, PA).
Cell surface biotinylation
Biotinylation of cell surface proteins was performed using the Cell Surface Protein Isolation Kit according to the manufacturer’s instructions with modifications. COS-7 cells were transfected with pZmISBT-EGFP2, as described above, and incubated for 2 days. The cells were washed twice with ice-cold phosphate-buffered saline (PBS; 0.1 M sodium phosphate, 0.15 M NaCl, pH 7.2) and then covered with a membrane-impermeable biotinylating reagent (2.0 mL of 1.5 mg/mL sulfo-NHS-SS-biotin dissolved in ice-cold PBS) at 4°C for 30 min with constant agitation. The reaction was stopped by adding 100 μL of quenching solution (provided as a component of the kit) and washed with Tris-buffered saline (0.025 M Tris-HCl, 0.15 M NaCl, pH 7.2). The cells were then covered with 700 μL of lysis buffer (150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% Triton X-100, 10 mM Tris-HCl, pH 7.4) supplemented with protease inhibitors (2 mM phenylmethylsufonyl fluoride, 0.022 trypsin inhibitor units/mL aprotinin, 5 μg/mL leupeptin, 0.1 μg/mL pepstatin) at 4°C for 1 h with constant agitation. The lysate was centrifuged at 13,000 rpm at 4°C for 10 min, and 600 μL of the supernatant was collected. The supernatant was incubated with 40 μL of 50% (vol/vol) streptavidin-agarose beads for 1 h with constant agitation. The mixture was centrifuged at 13,000 rpm for 2 min, and the supernatant was discarded. The beads were washed 4 times with ice-cold lysis buffer and suspended in 20 μL of 2 × SDS sample buffer (30% glycerol, 1% SDS, 0.093 g/mL DTT, 0.12 mg/mL bromophenol blue, 0.35 M Tris-HCl, pH 6.8). Ten microliters of the samples was subjected to 7.5% SDS-polyacrylamide gel electrophoresis, and western blotting was performed using anti-GFP antibody. The blots were then immersed in 0.2 M NaOH for 5 min to remove antibodies, and washed with distilled water for 5 min. The blots were reprobed with anti-calnexin antibody. The relative intensities of the protein bands were analyzed using Image J software (http://rsb.info.nih.gov/ij/).
Plasma membrane fractionation
The plasma membrane fraction was extracted from cells cultured in a 10-cm dish using the Plasma Membrane Protein Extraction Kit (Biovision, Milpitas, CA), according to the manufacturer’s instructions.
Immunofluorescence microscopy and surface ELISA
COS-7 cells were transfected with pSV40-T7-mSLC10A2. Two days after transfection, the cells were washed 3 times with PBS and incubated with 4% paraformaldehyde dissolved in PBS for 20 min at room temperature. The cells were then washed 3 times with PBS. For immunofluorescence under permeabilized conditions, the cells were incubated with 0.2% Triton X-100 for 20 min and blocked with 1% BSA in PBS for 30 min at room temperature. For nonpermeabilized conditions, incubation with Triton X-100 was omitted. The cells were incubated with anti-T7 tag monoclonal antibody at 1/2000 dilution for 30 min at room temperature. The cells were washed 3 times with PBS and incubated with fluorescein-conjugated anti-mouse antibody at 1/500 dilution for 1 h in the dark. The cells were stained with 10 μg/mL Hoechst 33342 for 5 min and washed 3 times with PBS in the dark. The cells were examined under a microscope (Axio Imager M1; Carl Zeiss, Tokyo, Japan), and images were captured using a digital camera (AxioCam MRm; Carl Zeiss). For surface ELISA, the cells were incubated with HRP-conjugated anti-T7 tag monoclonal antibody at 1/2000 dilution for 1 h at room temperature. The cells were washed 3 times with PBS, and incubated with SuperSignal ELISA Femto Maximum Sensitivity Substrate (Pierce) for 1 min at room temperature. Luminescence was measured using a plate reader (2030 ARVO X3; PerkinElmer).
Alignment of amino acid sequences
The nucleotide sequences of the related genes were retrieved by a BLAST search (tblastn program provided at http://blast.ncbi.nlm.nih.gov/) using the amino acid sequence “GCCPGGTGSNILAYWIDGDMDLSVSMTTCSTLLALGMMP” corresponding to Gly104–Pro142 of mouse Slc10a2 (mSlc10a2) as a query sequence. The deduced amino acid sequences of 10 of the identified genes from bacteria, archaea, and plants that yielded the highest score and the amino acid sequence of ASBTNM were compared with the amino acid sequences of SLC10A family members using the ClustalW software. The amino acid sequences were deduced from GenBank nucleotide sequences with the following accession numbers: Arthrobacter phenanthrenivorans, [CP002379]; Deinococcus proteolyticus, [CP002537]; Prevotella ruminicola, [CP002006]; Haloarcula marismortui, [AY596296]; Haloarcula hispanica, [CP002923]; Haloferax volcanii, [CP001956]; Haloterrigena turkmenica, [CP001860]; Methanococcus maripaludis, [CP000609]; Methanococcus vannielii, [CP000742]; Methanococcus voltae, [CP002057]; Staphylococcus pseudintermedius, [CP002439]; Megasphaera elsdenii, [HE576794]; Oceanobacillus iheyensis, [BA000028]; Geobacillus thermoglucosidasius, [CP002835]; Methanosarcina acetivorans, [AE010299]; Methanosarcina mazei, [AE008384]; Methanosarcina barkeri, [CP000099]; Arabidopsis lyrata, [XM_002889153]; Arabidopsis thaliana, [BX816582]; Solanum lycopersicum, [AK320352]; Ricinus communis, [XM_002531199]; Selaginella moellendorffii, [FJ51633]; Medicago truncatula, [XM_003638354]; Glycine max, [XM_003543135]; Leptospira interrogans, [AE010301]; Nitrosomonas sp. Is79A3, [CP002876]; Zea mays, [NM_001158879]; Sorghum bicolor, [XM_002442850]; Oryza sativa, [NM_001189880]; Leptospira biflexa, [CP000786]; SLC10A1/Slc10a1, dog, [XM_537494]; human, [NM_003049]; rabbit, [NM_001082768]; cattle, [BC105471]; mouse, [NM_011387]; rat, [NM_017047]; SLC10A2/Slc10a2, chimpanzee, [XM_522716]; human, [NM_000452]; orangutan, [NM_001131608]; Macaca mulatta (rhesus monkey), [XM_001095212]; dog, [NM_001002968]; rabbit, [NM_001082764]; mouse, [NM_011388]; rat, [NM_017222]; hamster, [NM_001246820]; cattle, [XM_604179]; platypus, [XM_001513315], chicken, [XM_425589]; opossum, [XM_001376304]; human SLC10A3, [NM_019848]; SLC10A4, [NM_152679]; SLC10A5, [NM_001010893]; SLC10A6/Slc10a6, chimpanzee, [XM_526626]; human, [NM_197965]; monkey, [XM_001092284]; dog, [XM_846210]; cattle, [NM_001081738]; mouse, [NM_029415]; rat, [NM_198049]; platypus, [XM_001515822]. The amino acid sequence of ASBTNM was obtained from UniProt [Q9K0A9].
TCA uptake and biotinylation results were analyzed by Dunnett’s test and Student’s t-test using the JMP software (SAS Institute, Tokyo, Japan).
Enhanced green fluorescent protein
Mouse solute carrier family 10 member 2
- Houten SM, Watanabe M, Auwerx J: Endocrine functions of bile acids. EMBO J 2006, 25: 1419-1425. 10.1038/sj.emboj.7601049View ArticlePubMedPubMed CentralGoogle Scholar
- Jung D, Inagaki T, Gerard RD, Dawson PA, Kliewer SA, Mangelsdorf DJ, Moschetta A: FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. J Lipid Res 2007, 48: 2693-2700. 10.1194/jlr.M700351-JLR200View ArticlePubMedGoogle Scholar
- Kim I, Ahn SH, Inagaki T, Choi M, Ito S, Guo GL, Kliewer SA, Gonzalez FJ: Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 2007, 48: 2664-2672. 10.1194/jlr.M700330-JLR200View ArticlePubMedGoogle Scholar
- Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B: Identification of a nuclear receptor for bile acids. Science 1999, 284: 1362-1365. 10.1126/science.284.5418.1362View ArticlePubMedGoogle Scholar
- Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM: Bile acids: natural ligands for an orphan nuclear receptor. Science 1999, 284: 1365-1368. 10.1126/science.284.5418.1365View ArticlePubMedGoogle Scholar
- Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, Schoonjans K, Bianco AC, Auwerx J: Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006, 439: 484-489. 10.1038/nature04330View ArticlePubMedGoogle Scholar
- Craddock AL, Love MW, Daniel RW, Kirby LC, Walters HC, Wong MH, Dawson PA: Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol 1998, 274: G157-G169.PubMedGoogle Scholar
- Shneider BL: Intestinal bile acid transport: biology, physiology, and pathophysiology. J Pediatr Gastroenterol Nutr 2001, 32: 407-417. 10.1097/00005176-200104000-00002View ArticlePubMedGoogle Scholar
- Wong MH, Oelkers P, Craddock AL, Dawson PA: Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. J Biol Chem 1994, 269: 1340-1347.PubMedGoogle Scholar
- Weinman SA, Carruth MW, Dawson PA: Bile acid uptake via the human apical sodium-bile acid cotransporter is electrogenic. J Biol Chem 1998, 273: 34691-34695. 10.1074/jbc.273.52.34691View ArticlePubMedGoogle Scholar
- Balakrishnan A, Wring SA, Polli JE: Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation. Pharm Res 2006, 23: 1451-1459. 10.1007/s11095-006-0219-4View ArticlePubMedPubMed CentralGoogle Scholar
- Tolle-Sander S, Lentz KA, Maeda DY, Coop A, Polli JE: Increased acyclovir oral bioavailability via a bile acid conjugate. Mol Pharm 2004, 1: 40-48. 10.1021/mp034010tView ArticlePubMedGoogle Scholar
- Hagenbuch B, Meier PJ: Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J Clin Invest 1994, 93: 1326-1331. 10.1172/JCI117091View ArticlePubMedPubMed CentralGoogle Scholar
- Hallén S, Branden M, Dawson PA, Sachs G: Membrane insertion scanning of the human ileal sodium/bile acid co-transporter. Biochemistry 1999, 38: 11379-11388. 10.1021/bi990554iView ArticlePubMedGoogle Scholar
- Banerjee A, Ray A, Chang C, Swaan PW: Site-directed mutagenesis and use of bile acid-MTS conjugates to probe the role of cysteines in the human apical sodium-dependent bile acid transporter (SLC10A2). Biochemistry 2005, 44: 8908-8917. 10.1021/bi050553sView ArticlePubMedGoogle Scholar
- Banerjee A, Swaan PW: Membrane topology of human ASBT (SLC10A2) determined by dual label epitope insertion scanning mutagenesis. New evidence for seven transmembrane domains. Biochemistry 2006, 45: 943-953. 10.1021/bi052202jView ArticlePubMedPubMed CentralGoogle Scholar
- Hallén S, Mareninova O, Branden M, Sachs G: Organization of the membrane domain of the human liver sodium/bile acid cotransporter. Biochemistry 2002, 41: 7253-7266. 10.1021/bi012152sView ArticlePubMedGoogle Scholar
- Mareninova O, Shin JM, Vagin O, Turdikulova S, Hallen S, Sachs G: Topography of the membrane domain of the liver Na+-dependent bile acid transporter. Biochemistry 2005, 44: 13702-13712. 10.1021/bi051291xView ArticlePubMedGoogle Scholar
- Zhang EY, Phelps MA, Banerjee A, Khantwal CM, Chang C, Helsper F, Swaan PW: Topology scanning and putative three-dimensional structure of the extracellular binding domains of the apical sodium-dependent bile acid transporter (SLC10A2). Biochemistry 2004, 43: 11380-11392. 10.1021/bi049270aView ArticlePubMedGoogle Scholar
- Hu NJ, Iwata S, Cameron AD, Drew D: Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT. Nature 2011, 478: 408-411. 10.1038/nature10450View ArticlePubMedPubMed CentralGoogle Scholar
- Sun AQ, Salkar R, Sachchidanand , Xu S, Zeng L, Zhou MM, Suchy FJ: A 14-amino acid sequence with a beta-turn structure is required for apical membrane sorting of the rat ileal bile acid transporter. J Biol Chem 2003, 278: 4000-4009. 10.1074/jbc.M207163200View ArticlePubMedGoogle Scholar
- Hussainzada N, Banerjee A, Swaan PW: Transmembrane domain VII of the human apical sodium-dependent bile acid transporter ASBT (SLC10A2) lines the substrate translocation pathway. Mol Pharmacol 2006, 70: 1565-1574. 10.1124/mol.106.028647View ArticlePubMedGoogle Scholar
- Hussainzada N, Da Silva TC, Zhang EY, Swaan PW: Conserved Aspartic Acid Residues Lining the Extracellular Loop I of Sodium-coupled Bile Acid Transporter ASBT Interact with Na+ and 7α-OH Moieties on the Ligand Cholestane Skeleton. J Biol Chem 2008, 283: 20653-20663. 10.1074/jbc.M802885200View ArticlePubMedPubMed CentralGoogle Scholar
- Khantwal CM, Swaan PW: Cytosolic half of transmembrane domain IV of the human bile acid transporter hASBT (SLC10A2) forms part of the substrate translocation pathway. Biochemistry 2008, 47: 3606-3614. 10.1021/bi702498wView ArticlePubMedGoogle Scholar
- Geyer J, Wilke T, Petzinger E: The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships. Naunyn Schmiedebergs Arch Pharmacol 2006, 372: 413-431. 10.1007/s00210-006-0043-8View ArticlePubMedGoogle Scholar
- Zahner D, Eckhardt U, Petzinger E: Transport of taurocholate by mutants of negatively charged amino acids, cysteines, and threonines of the rat liver sodium-dependent taurocholate cotransporting polypeptide Ntcp. Eur J Biochem 2003, 270: 1117-1127. 10.1046/j.1432-1033.2003.03463.xView ArticlePubMedGoogle Scholar
- Rzewuski G, Sauter M: The novel rice (Oryza sativa L.) gene OsSbf1 encodes a putative member of the Na+/bile acid symporter family. J Exp Bot 2002, 53: 1991-1993. 10.1093/jxb/erf053View ArticlePubMedGoogle Scholar
- Saeki T, Mizushima S, Ueda K, Iwami K, Kanamoto R: Mutational analysis of uncharged polar residues and proline in the distal one-third (Thr130–Pro142) of the highly conserved region of mouse Slc10a2. Biosci Biotechnol Biochem 2009, 73: 1535-1540. 10.1271/bbb.90023View ArticlePubMedGoogle Scholar
- Kanamoto R, Azuma N, Suda H, Saeki T, Tsuchihashi Y, Iwami K: Elimination of Na+-dependent bile acid transporter from small intestine by ileum resection increases [correction of increase] colonic tumorigenesis in the rat fed deoxycholic acid. Cancer Lett 1999, 145: 115-120. 10.1016/S0304-3835(99)00240-2View ArticlePubMedGoogle Scholar
- Wang W, Xue S, Ingles SA, Chen Q, Diep AT, Frankl HD, Stolz A, Haile RW: An association between genetic polymorphisms in the ileal sodium-dependent bile acid transporter gene and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2001, 10: 931-936.PubMedGoogle Scholar
- Oelkers P, Kirby LC, Heubi JE, Dawson PA: Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). J Clin Invest 1997, 99: 1880-1887. 10.1172/JCI119355View ArticlePubMedPubMed CentralGoogle Scholar
- Renner O, Harsch S, Schaeffeler E, Schwab M, Klass DM, Kratzer W, Stange EF: Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression. Hum Genet 2009, 125: 381-391. 10.1007/s00439-009-0630-0View ArticlePubMedGoogle Scholar
- Saeki T, Matoba K, Furukawa H, Kirifuji K, Kanamoto R, Iwami K: Characterization, cDNA cloning, and functional expression of mouse ileal sodium-dependent bile acid transporter. J Biochem (Tokyo) 1999, 125: 846-851. 10.1093/oxfordjournals.jbchem.a022358View ArticleGoogle Scholar
- Saeki T, Munetaka Y, Ueda K, Iwami K, Kanamoto R: Effects of Ala substitution for conserved Cys residues in mouse ileal and hepatic Na+-dependent bile acid transporters. Biosci Biotechnol Biochem 2007, 71: 1865-1872. 10.1271/bbb.70037View ArticlePubMedGoogle Scholar